[ad_1]
The 2019 Gulf Pharmaceutical Summit, which opened Monday in Dubai, highlights global best practices in drug regulation, public health systems, and a focus on key medical innovations.
Dr. Amin Hussein Al Amiri, Assistant Under-Secretary for Public Health Policy and Licensing of the Ministry of Health and Community Protection, opened the fourth edition of the Summit, bringing together more than 300 health professionals and responsible for the sector of the registration and pricing of pharmaceuticals, as well as a series of actors of the protection of intellectual property. Current and future trends and pace of growth of the pharmaceutical sector in GCC countries.
More than 40 regional and international experts will discuss current and planned regulatory requirements in the pharmaceutical sector and the most important strategies that GCC countries should take to provide world-class healthcare to their residents and visitors.
Dr. Najeeba Al Shezawi, president of PRA, organizer of the event, stressed the importance of the summit, which is an essential platform for sharing information on the future direction of the industry and the development of the systems. health and medicine in the region.
Shezawi added that the attention of many decision makers in the health and medicine sector is focused on best practices for keeping abreast of current challenges in regional and international markets and that as a result, the Event calendar is tailored to the needs of specialists to anticipate the requirements and challenges in the field of registration, pharmaceutical products and pharmaceutical prices. In the pharmaceutical sector, which invests in the UAE and GCC markets, which in turn is experiencing continued growth in demand.
According to a recent report by Fitch Ratings, a subsidiary of the rating agency Fitch, the GCC pharmaceutical sector will continue to grow over the next decade, rising from $ 13.9 billion in 2018 to $ 25.7 billion. dollars in 2028.
Source link
